EverGlade Assists Detect, Inc. with $22m in Federal Funding
EverGlade Consulting (“EverGlade”), a Washington, D.C. based consulting firm, has successfully aided Detect, Inc. (“Detect”) in securing a contract with BARDA for the advanced development of a next-generation diagnostic device which is an over-the-counter home test that identifies and distinguishes between SARS-CoV-2 and influenza A and B nucleic acid using a single nasal swab. […]
EverGlade Assists Detect, Inc. with $22m in Federal Funding Read More »
